Privia Health's EHR Cancer Screening Gains Put Value Based Story In Focus [Yahoo! Finance]
Privia Health Group, Inc. (PRVA)
Company Research
Source: Yahoo! Finance
Privia Health Group (NasdaqGS:PRVA) recently reported major progress in colorectal cancer screening outcomes tied to its EHR integrated patient outreach program. The program has been rolled out at national scale and is linked with screening rates that exceed key benchmarks. The results highlight measurable gains in preventive care that are being achieved through technology focused partnerships. For investors tracking Privia Health Group at a share price of $23.27, this news adds fresh context to a stock that has seen mixed performance, including a 5.8% gain over the past 30 days and a 1 year decline of 8.9%. The 3 year return of 9.8% and a value score of 3 may prompt some readers to look more closely at how the company's care model and technology investments line up with its current valuation. The colorectal cancer screening results also speak to how Privia Health's model could be applied to other preventive areas, which may be relevant for anyone thinking about the company's
Show less
Read more
Impact Snapshot
Event Time:
PRVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRVA alerts
High impacting Privia Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
PRVA
News
- Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle ExcellenceGlobeNewswire
- Privia Health Group CFO Sells $283,000 Worth of Shares to Cover Taxes [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for Privia Health Stock Options [Yahoo! Finance]Yahoo! Finance
- Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]Yahoo! Finance
- Privia Health Group (PRVA) had its price target lowered by Citigroup Inc. from $34.00 to $32.00. They now have a "buy" rating on the stock.MarketBeat
PRVA
Earnings
- 2/26/26 - Beat
PRVA
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- 3/16/26 - Form 4
- PRVA's page on the SEC website